US › Healthcare

PetMed Express Inc (PETS)

US · Healthcare · Pharmaceutical Retailers

$1.62+1.25%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$41.0M

Revenue YoY

-19.9%

Net profit

$-6.1M

EPS

$-0.28

EPS estimate

$0.12

Net margin

-15.0%

EPS came in at -0.28 against a street estimate of 0.12 — a miss of 333.3%.

Key statistics

Market cap

$35.8M

Forward P/E

16.7

P/B

1.56

Book value

$1.09

EPS (TTM)

$-1.37

52-week high

$4.10

52-week low

$1.57

50-day MA

$1.90

200-day MA

$2.37

Beta

0.79

Analyst view

Analysts rate PetMed Express Inc a sell (0 buy, 1 hold, 1 sell out of 2) with an average price target of $2.15.

Shareholding

Insiders

16.40%

Institutions

37.85%

Largest institutional holders

Fund	Stake
Renaissance Technologies Corp	5.47%
Vanguard Capital Management, LLC	3.84%
BlackRock Inc	2.54%
Hotchkis & Wiley Capital Management LLC	2.37%
UBS Group AG	1.08%
Geode Capital Management, LLC	1.02%
Federated Hermes Inc	0.98%
Steel Partners Holdings LP	0.89%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for PetMed Express Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.